검색어 : 통합검색[Key Keegan-Michael]
총 3건 중 3건 출력
, 1/1 페이지
-
1
- Abstract 40: NCI patient derived models repository: PDX, organoid and cell lines from the same patient - bridging the translational pipeline
- Evrard, Yvonne A.; Chen, Li; Alcoser, Sergio; Bliss, Gareth; Bonomi, Carrie; Borgel, Suzanne; Carter, John; Chang, Ting-Chia; Chen, Alice; Cooper, Kevin; Das, Biswajit; Dougherty, Kelly; Dutko, Lindsay; Gibson, Marion; Ahalt-Gottholm, Michelle M.; Grinnage-Pulley, Tara; Kalmbach, Keegan; Karlovich, Chris; Klarmann, Kimberly; Jiwani, Shahanawaz; Miner, Tiffanie; Mullendore, Michael; Murphy, Matthew; Plater, Kevin; Rivera, Gloryvee; Steed, Jessica; Stockwin, Luke; Timme, Cindy R.; Newton, Dianne L.; Williams, Paul Mickey; Hollingshead, Melinda G.; Doroshow, James H.; 1Frederick National Laboratory for Cancer Research, Frederick, MD; ; 1Frederick National Laboratory for Cancer Research, Frederick, MD; ; 2National Cancer Institute at Frederick, Frederick, MD; ; 1Frederick National Laboratory for Cancer Research, Frederick, MD; ; 1Frederick National Laboratory for Cancer Research, Frederick, MD; ; 1Frederick National Laboratory for Cancer Research, Frederick, MD; ; 1Frederick National Laboratory for Cancer Research, Frederick, MD; ; 1Frederick National Laboratory for Cancer Research, Frederick, MD; ; 3National Cancer Institute, Bethesda, MD.; 1Frederick National Laboratory for Cancer Research, Frederick, MD; ; 1Frederick National Laboratory for Cancer Research, Frederick, MD; ; 1Frederick National Laboratory for Cancer Research, Frederick, MD; ; 1Frederick National Laboratory for Cancer Research, Frederick, MD; ; 1Frederick National Laboratory for Cancer Research, Frederick, MD; ; 2National Cancer Institute at Frederick, Frederick, MD; ; 2National Ca; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.83, 2023, pp.40-40)
-
2
- Abstract LB-150: Neoantigens that fail to elicit measurable T cell responses following peptide immunization can control tumor growth when delivered using a <i>Listeria</i>-based immunotherapy platform
- Coder, Brandon; Phee, Hyewon; Mottershead, Cristina; Kelkar, Dipti; Filippova, Elena; Ju, Xiaoming; Lugt, Bryan Vander; Pryshchep, Olga; Lesch, Justin; Liu, Xian; DeVoss, Jason; Cooke, Keegan; Liu, Claret; Zhan, Jinghui; Mitchell, Petia; Ramos, Kim; Villarreal, Daniel O.; Johnston, Jim; Petit, Robert; Princiotta, Michael; ; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.78, 2018, pp.LB-150-LB-150)
-
3
- Abstract CT002: CTX130 allogeneic CRISPR-Cas9-engineered chimeric antigen receptor (CAR) T cells in patients with advanced clear cell renal cell carcinoma: Long-term follow-up and translational data from the phase 1 COBALT-RCC study
- Pal, Sumanta Kumar; Tran, Ben; Haanen, John B.; Hurwitz, Michael; Sacher, Adrian; Agarwal, Neeraj; Tannir, Nizar; Budde, Elizabeth; Harrison, Simon; Klobuch, Sebastian; Patel, Sagar S.; Dequeant, Mary-Lee; He, Qiuling Ally; Keegan, Alissa; Dar, Henia; Ma, Anna; Morrow, PK; Srour, Samer A.; 1City of Hope Comprehensive Cancer Center, Duarte, CA; ; 2Peter MacCallum Cancer Centre, Melbourne, Australia; ; 3Netherlands Cancer Institute, Amsterdam, Netherlands; ; 4Yale School of Medicine, New Haven, CT; ; 5Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; ; 6Huntsman Cancer Institute, University of Utah Comprehensive Cancer Center, Salt Lake City, UT; ; 7The University of Texas MD Anderson Cancer Center, Houston, TX; ; 1City of Hope Comprehensive Cancer Center, Duarte, CA; ; 2Peter MacCallum Cancer Centre, Melbourne, Australia; ; 3Netherlands Cancer Institute, Amsterdam, Netherlands; ; 6Huntsman Cancer Institute, University of Utah Comprehensive Cancer Center, Salt Lake City, UT; ; 8CRISPR Therapeutics, Boston, MA.; 8CRISPR Therapeutics, Boston, MA.; 8CRISPR Therapeutics, Boston, MA.; 8CRISPR Therapeutics, Boston, MA.; 8CRISPR Therapeutics, Boston, MA.; 8CRISPR Therapeutics, Boston, MA.; 7The University of Texas MD Anderson Cancer Cente; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.84, 2024, pp.CT002-CT002)
1
QUICK MENU
